The stage at which cancers are detected is one of the most important factors in determining patient survival. Yet not everyone regularly receives recommended routine screenings for common cancers, which contributes to disparities in cancer survival rates among Black and Latino patients.
A new white paper published by the USC Schaeffer Center focuses on the potential benefit of multi-cancer early detection (MCED) blood-based tests to reduce disparities in late-stage cancer diagnosis among minority populations. A single test can detect multiple cancers and does not require a specialist to administer it, write the authors.
To continue reading this story, click here.